Atlas Trials

Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer

Clinical trial NCT06898437 · RECRUITING

Trial details

NCT number
NCT06898437
Sponsor
Peking Union Medical College Hospital
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Radioiodine Refractory Differentiated Thyroid Cancer
Start date
2025-03-24
Primary completion
2026-03-23
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.